EMJ Oncology 7 [Suppl 2] . 2019

Komal Jhaveri – Breast Medical Oncologist and Early Drug Development Specialist, Memorial Sloan Kettering Cancer Center, New York, USA… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

Dr. Joshua Sabari explores recent advances in the treatment of HER2-mutant non-small cell lung cancer, including a newly FDA-approved option… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.